Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ficarra

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Pharmaceutical and Biomedical Analysis|July 25, 2006
Optimization of a LC method for the enantioseparation of a non-competitive glutamate receptor antagonist, by experimental design methodologyP Donato, R Stancanelli, M L Calabrò, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 11, 2008
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complexR Stancanelli, R Ficarra, C Cannavà, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 6, 2004
Effects of alpha- and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavonesM L Calabrò, S Tommasini, P Donato, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2000
Stability study of piroxicam and cinnoxicam in solid pharmaceuticalsR Ficarra, A Villari, N Micali, et al.
Bollettino Chimico Farmaceutico|May 1, 1997
Isolation and characterization of Guiera senegalensis J.F.Gmel. active principlesR Ficarra, P Ficarra, S Tommasini, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Pharmaceutical and Biomedical Analysis|July 25, 2006
Optimization of a LC method for the enantioseparation of a non-competitive glutamate receptor antagonist, by experimental design methodologyP Donato, R Stancanelli, M L Calabrò, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 11, 2008
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complexR Stancanelli, R Ficarra, C Cannavà, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 6, 2004
Effects of alpha- and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavonesM L Calabrò, S Tommasini, P Donato, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2000
Stability study of piroxicam and cinnoxicam in solid pharmaceuticalsR Ficarra, A Villari, N Micali, et al.
Bollettino Chimico Farmaceutico|May 1, 1997
Isolation and characterization of Guiera senegalensis J.F.Gmel. active principlesR Ficarra, P Ficarra, S Tommasini, et al.
Pageof 5